The Institute opens its doors to the international EWALL Committee
Dr Josep Maria Ribera hosted one of the two yearly meetings of the European Working Group on Adult Lymphoblastic Leukemia (EWALL) on 29 June at the Josep Carreras Leukaemia Research Institute.
The EWALL working group forms a part of the European Hematology Association (EHA) and also of the European LeukemiaNet (EL:N), it has an itinerant meeting that changes location each year and a meeting every autumn in Paris. This year Dr Ribera was delighted to welcome the international team to the ICO-GTIP Campus of the institute.
“The purpose of the group is to improve coordination between organizations responsible for healthcare of patients and research across Europe,” explained Dr Ribera, who is on the EWALL steering Committee as the Chairman of PETHEMA, the Spanish Hematology Treatment Programme. EWALL has three main objectives; firstly to exchange experiences on acute lymphoblastic leukemia (ALL), secondly the group coordinates international clinical trials on minority sub-types of leukemia for which there are only small numbers of patients, making a viable trial impossible in only one country. A third and very important task is to design guidelines for the management of ALL patients (as those from the European Society for Medical Oncology [ESMO]) and to elaborate a manual for diagnosis and treatment of ALL. “It is very absolutely necessary to harmonize protocols across countries and promote the sharing of information,” Dr Ribera tells us, “this increases synergy and saves resources and allows each country to respond better to the needs of its patients.”
In the meeting this June, the EWALL Group defined its contribution to the HARMONY project, a project on haematological malignancies founded by the European Union, in which theJosep Carreras Leukaemia Research Institute is already participating.